Lv42
480 积分 2024-07-10 加入
The Subretinal Fluid Tolerance Post Faricimab Injection Short Case Review Study
3小时前
已关闭
Faricimab in neovascular AMD: first report of real-world outcomes in an independent retina clinic
3小时前
已完结
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration
3小时前
已完结
Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF Therapy
19小时前
已完结
Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration
20小时前
已完结
Outcomes of Treatment-Resistant Neovascular Age-Related Macular Degeneration Switched from Aflibercept to Faricimab
20小时前
已完结
Investigation of satisfaction with short-term outcomes after switching to faricimab to treat neovascular age-related macular degeneration
20小时前
已完结
Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration
20小时前
已完结
Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study
20小时前
已完结
Retreatment interval lengthening achieved in two thirds of eyes with prolonged intensive anti‐VEGF therapy for neovascular age‐related macular degeneration after switching to faricimab
20小时前
已完结
皖公网安备34019202002308
